NorthCrest Asset Manangement »

Vanda Pharmaceuticals shares owned by NorthCrest Asset Manangement

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by NorthCrest Asset Manangement from 13F filings

Historical chart of NorthCrest Asset Manangement investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by NorthCrest Asset Manangement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by NorthCrest Asset Manangement

Quarter filed Position value Share count Share price at filing
2026-06-30 $83k 13k 6.38

More positions owned by NorthCrest Asset Manangement

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Apple (AAPL)
Applied Materials (AMAT)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Caterpillar (CAT)
JPMorgan Chase & Co. (JPM)
Goldman Sachs (GS)
Johnson & Johnson (JNJ)
Bank of America Corporation (BAC)
Amphenol Corp Cl A (APH)

View all positions for NorthCrest Asset Manangement

Top funds holding Vanda Pharmaceuticals

BlackRock
AQR Capital Management
Renaissance Technologies
State Street Corporation
Vanguard Capital Management
AIGH Capital Management
Acadian Asset Management
Dimensional Fund Advisors
Millennium Management
Geode Capital Management
Two Sigma Investments
Marshall Wace
Jacobs Levy Equity Management
Krensavage Asset Management
Vanguard Portfolio Management

View all funds holding Vanda Pharmaceuticals